Pfizer says COVID-19 vaccine works in kids ages 5 to 11
The Hindu
The kid dosage also proved safe, with similar or fewer temporary side effects— such as sore arms, fever or achiness.
Pfizer said on Monday, its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon— a key step toward beginning vaccinations for youngsters.
The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.
For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now. Yet after their second dose, children ages 5 to 11 developed coronavirus-fighting antibody levels just as strong as teenagers and young adults, Dr. Bill Gruber, a Pfizer senior vice president, told The Associated Press.

The Central Committee of the Communist Party of India (Marxist) on Friday pledged to mobilise people in resistance against the BJP-led Union government’s “anti-agricultural worker, anti-farmer, anti-worker, anti-people” laws and policies till they are all repealed, the party said on Friday. In a statement issued here, the CPI(M) said the members took the pledge following a three-day meeting held at Thiruvananthapuram.

Expressing the need for more number of socially responsive engineers and lawyers for furthering development of the country, Governor Thaawarchad Gehlot here on Friday lauded St. Aloysius institution for widening its service in the education sector by opening separate institutes for engineering and law











